Literature DB >> 9014296

Mapping of protective and cross-reactive domains of the type A neurotoxin of Clostridium botulinum.

M T Dertzbaugh1, M W West.   

Abstract

The purpose of this study was to identify the location of domains within the serotype A neurotoxin of Clostridium botulinum (BoNT/A) that conferred protection against botulism. The BoNT/A gene was subcloned into a series of 10 overlapping fragments that were expressed in Escherichia coli. The expressed proteins were partially purified and used to immunize mice. The resulting antisera were screened by immunoblotting analysis for the presence of BoNT/A-specific antibody. All fragments, except one, elicited antibody that recognized BoNT/A in an immunoblot. Serological screening identified several fragment-specific cross-reactive epitopes that were shared by heterologous serotypes of BoNT. Most of these epitopes immunoreactive by enzyme-linked immunosorbent assay, but not by immunoblot. Only two fragments were shown to confer protection against BoNT/A intoxication. Both of these proteins were derived from segments of the heavy chain and encoded amino acid residues H455-661 and H1150-1289 of BoNT/A.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9014296     DOI: 10.1016/s0264-410x(96)00094-1

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

1.  High-affinity, protective antibodies to the binding domain of botulinum neurotoxin type A.

Authors:  D D Pless; E R Torres; E K Reinke; S Bavari
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

2.  Epitope mapping of neutralizing botulinum neurotoxin A antibodies by phage display.

Authors:  B P Mullaney; M G Pallavicini; J D Marks
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

3.  Subunit vaccine efficacy against Botulinum neurotoxin subtypes.

Authors:  James S Henkel; William H Tepp; Amanda Przedpelski; Robert B Fritz; Eric A Johnson; Joseph T Barbieri
Journal:  Vaccine       Date:  2011-08-10       Impact factor: 3.641

4.  An atypical outbreak of food-borne botulism due to Clostridium botulinum types B and E from ham.

Authors:  Christelle Mazuet; Jean Sautereau; Christine Legeay; Christiane Bouchier; Philippe Bouvet; Michel R Popoff
Journal:  J Clin Microbiol       Date:  2014-11-26       Impact factor: 5.948

5.  Adenovirus F protein as a delivery vehicle for botulinum B.

Authors:  Beata Clapp; Sarah Golden; Massimo Maddaloni; Herman F Staats; David W Pascual
Journal:  BMC Immunol       Date:  2010-07-07       Impact factor: 3.615

6.  Use of biophysical characterization in preformulation development of a heavy-chain fragment of botulinum serotype B: evaluation of suitable purification process conditions.

Authors:  Frank K Bedu-Addo; Catharine Johnson; Shanthini Jeyarajah; Ian Henderson; Siddharth J Advant
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

7.  Enhancing the protective immune response against botulism.

Authors:  Amanda Przedpelski; William H Tepp; Abby R Kroken; Zhuji Fu; Jung-Ja P Kim; Eric A Johnson; Joseph T Barbieri
Journal:  Infect Immun       Date:  2013-05-13       Impact factor: 3.441

8.  Protective immunity against botulism provided by a single dose vaccination with an adenovirus-vectored vaccine.

Authors:  Mingtao Zeng; Qingfu Xu; Md Elias; Michael E Pichichero; Lance L Simpson; Leonard A Smith
Journal:  Vaccine       Date:  2007-09-05       Impact factor: 3.641

9.  Antibody protection against botulinum neurotoxin intoxication in mice.

Authors:  Luisa W Cheng; Larry H Stanker; Thomas D Henderson; Jianlong Lou; James D Marks
Journal:  Infect Immun       Date:  2009-08-03       Impact factor: 3.441

10.  Llama single domain antibodies specific for the 7 botulinum neurotoxin serotypes as heptaplex immunoreagents.

Authors:  Jerry O Conway; Laura J Sherwood; M Thelma Collazo; John A Garza; Andrew Hayhurst
Journal:  PLoS One       Date:  2010-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.